Ratajczak B, Przybylowicz-Chalecka A, Czerwinska-Rybak J, Kandula Z, et al. The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure. Leuk Res 2023;132:107349.
PMID: 37393627